These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15084233)

  • 1. Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
    Miller KD
    Breast Cancer Res; 2004; 6(3):128-32. PubMed ID: 15084233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving forward with capecitabine: a glimpse of the future.
    Biganzoli L; Martin M; Twelves C
    Oncologist; 2002; 7 Suppl 6():29-35. PubMed ID: 12454317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of angiogenesis inhibition in the treatment of breast cancer.
    Sledge GW; Rugo HS; Burstein HJ
    Clin Adv Hematol Oncol; 2006 Oct; 4(10 Suppl 21):1-10; quiz 11-2. PubMed ID: 17139244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic agents in breast cancer.
    Salter JT; Miller KD
    Cancer Invest; 2007 Oct; 25(7):518-26. PubMed ID: 18027149
    [No Abstract]   [Full Text] [Related]  

  • 5. Current role of bevacizumab in colorectal cancer.
    Saltz L
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting angiogenesis in metastatic breast cancer.
    Reddy S; Raffin M; Kaklamani V
    Oncologist; 2012; 17(8):1014-26. PubMed ID: 22843553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiogenesis and breast cancer].
    Bachelot T; Ray-Coquard I; Cassier P; Blay JY
    Bull Cancer; 2007 Jul; 94 Spec No():S203-10. PubMed ID: 17846006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.
    Dellapasqua S; Bertolini F; Bagnardi V; Campagnoli E; Scarano E; Torrisi R; Shaked Y; Mancuso P; Goldhirsch A; Rocca A; Pietri E; Colleoni M
    J Clin Oncol; 2008 Oct; 26(30):4899-905. PubMed ID: 18794539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
    Orlando L; Cardillo A; Ghisini R; Rocca A; Balduzzi A; Torrisi R; Peruzzotti G; Goldhirsch A; Pietri E; Colleoni M
    BMC Cancer; 2006 Sep; 6():225. PubMed ID: 16978400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials.
    Valachis A; Polyzos NP; Patsopoulos NA; Georgoulias V; Mavroudis D; Mauri D
    Breast Cancer Res Treat; 2010 Jul; 122(1):1-7. PubMed ID: 20063120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine in combination with novel targeted agents in the management of metastatic breast cancer: underlying rationale and results of clinical trials.
    Tripathy D
    Oncologist; 2007 Apr; 12(4):375-89. PubMed ID: 17470680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for advanced breast cancer.
    Traina TA; Rugo HS; Dickler M
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):303-19. PubMed ID: 17512451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast tumour angiogenesis.
    Fox SB; Generali DG; Harris AL
    Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis inhibition in the treatment of lung cancer.
    Vokes E; Herbst R; Sandler A
    Clin Adv Hematol Oncol; 2006 Nov; 4(11 Suppl 23):1-10; quiz 11-2. PubMed ID: 17143257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab in the treatment of breast cancer.
    Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP
    Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic therapies in breast cancer.
    Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive review.
    Miles D; Zielinski C; Martin M; Vrdoljak E; Robert N
    Eur J Cancer; 2012 Mar; 48(4):482-91. PubMed ID: 22257791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab.
    Dellapasqua S; Bagnardi V; Bertolini F; Sandri MT; Pastrello D; Cancello G; Montagna E; Balduzzi A; Mancuso P; Luini A; Goldhirsch A; Colleoni M
    Breast; 2012 Jun; 21(3):309-13. PubMed ID: 22341133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
    Rastogi P; Buyse ME; Swain SM; Jacobs SA; Robidoux A; Liepman MK; Pajon ER; Dy PA; Posada JG; Melnik MK; Piette F; Geyer CE; Mamounas EP; Wolmark N
    Clin Breast Cancer; 2011 Aug; 11(4):228-34. PubMed ID: 21684812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Avastin in the treatment of breast cancer].
    Petráková K
    Klin Onkol; 2011; 24(2):101-5. PubMed ID: 21644364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.